Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tyrosine phosphatase PTP1B impairs presynaptic NMDA receptor-mediated plasticity in a mouse model of Alzheimer's disease
Li Zhang, Zhaohong Qin, Fariba Sharmin, et al.
Neurobiology of Disease (2021) Vol. 156, pp. 105402-105402
Open Access | Times Cited: 20

Showing 20 citing articles:

Protein tyrosine phosphatase 1B (PTP1B) as a potential therapeutic target for neurological disorders
Jordi Olloquequi, Amanda Cano, Elena Sánchez‐López, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113709-113709
Open Access | Times Cited: 39
Protein tyrosine phosphatase 1B (PTP1B) function, structure, and inhibition strategies to develop antidiabetic drugs
Andrea Coronell‐Tovar, Juan Pablo Pardo, Adela Rodrı́guez-Romero, et al.
FEBS Letters (2024)
Open Access | Times Cited: 11
The Q/R editing site of AMPA receptor GluA2 subunit acts as an epigenetic switch regulating dendritic spines, neurodegeneration and cognitive deficits in Alzheimer’s disease
Amanda L. Wright, Lyndsey M. Konen, Bruce G. Mockett, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 17
Regulation of Melatonin and Neurotransmission in Alzheimer’s Disease
Jaydeep Roy, Ka Chun Tsui, Jonah Ng, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6841-6841
Open Access | Times Cited: 40
Enhancement of neural regeneration as a therapeutic strategy for Alzheimer's disease (Review)
Junyan Gao, Liping Li
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 3
Open Access | Times Cited: 13
From Marine Metabolites to the Drugs of the Future: Squalamine, Trodusquemine, Their Steroid and Triterpene Analogues
О. Б. Казакова, G. V. Giniyatullina, Denis A. Babkov, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1075-1075
Open Access | Times Cited: 22
Disruptions in cellular communication: Molecular interplay between glutamate/NMDA signalling and MAPK pathways in neurological disorders
Sumedha Gupta, Abhishek Gupta, Sidharth Mehan, et al.
Neuroscience (2025)
Closed Access
Integrative single-cell RNA sequencing and mendelian randomization analysis reveal the potential role of synaptic vesicle cycling-related genes in Alzheimer's disease
Junfeng Zeng, Ruihua Zhang, Huihua Xu, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100097-100097
Open Access
Natural aminosterols inhibit NMDA receptors with low nanomolar potency
Giulia Fani, Elisabetta Coppi, Silvia Errico, et al.
FEBS Journal (2025)
Open Access
Molecular Mechanisms of Propofol‐Induced Cognitive Impairment: Suppression of Critical Hippocampal Pathways
Xiangdong Zhou, Shasha Dong, Yuhai Xu
Journal of Neurochemistry (2025) Vol. 169, Iss. 4
Closed Access
Metamodulation of presynaptic NMDA receptors: New perspectives for pharmacological interventions
Guendalina Olivero, Massimo Grilli, Mario Marchi, et al.
Neuropharmacology (2023) Vol. 234, pp. 109570-109570
Open Access | Times Cited: 7
Licochalcone A: A Potential Multitarget Drug for Alzheimer’s Disease Treatment
Jordi Olloquequi, Miren Ettcheto, Amanda Cano, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14177-14177
Open Access | Times Cited: 7
The Spread of Spectrin in Ataxia and Neurodegenerative Disease
Jon S. Morrow, Michael C. Stankewich
Journal of Experimental Neurology (2021) Vol. 2, Iss. 3
Open Access | Times Cited: 10
NMDARs in Alzheimer’s Disease: Between Synaptic and Extrasynaptic Membranes
Sergio Escamilla, Javier Sáez‐Valero, Inmaculada Cuchillo‐Ibáñez
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10220-10220
Open Access | Times Cited: 1
NMDA Inhibitors: A Potential Contrivance to Assist in Management of Alzheimer’s Disease
Sakshi Painuli, Prabhakar Semwal, Wissam Zam, et al.
Combinatorial Chemistry & High Throughput Screening (2022) Vol. 26, Iss. 12, pp. 2099-2112
Closed Access | Times Cited: 6
Effect of caffeine supplementation during treadmill exercise on hippocampal genes expression levels in adolescent rats
F. Bakir, Özge Selin Çevik, Seval Keloğlan, et al.
The European Research Journal (2023) Vol. 9, Iss. 2, pp. 348-358
Open Access | Times Cited: 2
N-methyl-D-aspartate receptor functions altered by neuronal PTP1B activation in Alzheimer’s disease and schizophrenia models
Alexandre F.R. Stewart, Hsiao‐Huei Chen
Neural Regeneration Research (2022) Vol. 17, Iss. 10, pp. 2208-2208
Open Access | Times Cited: 3
Uncovering the intricacies of O-GlcNAc modification in cognitive impairment: New insights from regulation to therapeutic targeting
Jianhui Wang, Ning Jiang, Feng Liu, et al.
Pharmacology & Therapeutics (2024), pp. 108761-108761
Closed Access
Does Metabolic Manager Show Encouraging Outcomes in Alzheimer's?: Challenges and Opportunity for Protein Tyrosine Phosphatase 1b Inhibitors
Ritu Singh, Smita Jain, Vartika Paliwal, et al.
Drug Development Research (2024) Vol. 85, Iss. 8
Open Access
Anti-aging properties of the aminosterols of the dogfish shark
Denise Barbut, Michele Perni, Michael Zasloff
npj Aging (2024) Vol. 10, Iss. 1
Open Access
Page 1

Scroll to top